CHIP-mediated degradation of transglutaminase 2 negatively regulates tumor growth and angiogenesis in renal cancer.
about
Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target.New Insights into Transglutaminase 2 and Links to Neurodegenerative Diseases.Covalent ISG15 conjugation to CHIP promotes its ubiquitin E3 ligase activity and inhibits lung cancer cell growth in response to type I interferon.Transglutaminase-2 promotes metastatic and stem-like phenotypes in osteosarcoma
P2860
CHIP-mediated degradation of transglutaminase 2 negatively regulates tumor growth and angiogenesis in renal cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
CHIP-mediated degradation of t ...... angiogenesis in renal cancer.
@en
CHIP-mediated degradation of t ...... angiogenesis in renal cancer.
@nl
type
label
CHIP-mediated degradation of t ...... angiogenesis in renal cancer.
@en
CHIP-mediated degradation of t ...... angiogenesis in renal cancer.
@nl
prefLabel
CHIP-mediated degradation of t ...... angiogenesis in renal cancer.
@en
CHIP-mediated degradation of t ...... angiogenesis in renal cancer.
@nl
P2093
P2860
P356
P1433
P1476
CHIP-mediated degradation of t ...... angiogenesis in renal cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2015.439
P407
P50
P577
2015-11-16T00:00:00Z